Eur Rev Med Pharmacol Sci 2019; 23 (11): 4842-4849
DOI: 10.26355/eurrev_201906_18071

MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4

W.-L- Wang, H.-R. Wang, W.-G. Ji, S.-L. Guo, H.-X. Li, X.-Y. Xu

Department of Hematopathology, Luoyang Central Hospital, Luoyang, China. wangmai510@163.com


OBJECTIVE: To examine the expression level of microRNA-485-5p (miRNA-485-5p) in acute myeloid leukemia (AML) and its biological function in regulating the proliferative ability of AML through targeting SALL4.
PATIENTS AND METHODS: Serum level of miRNA-485-5p in AML patients and healthy controls was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). MiRNA-485-5p level in AML cell lines was detected by qRT-PCR as well. Proliferative and apoptotic changes in AML5 and U937 cells overexpressing miRNA-485-5p were assessed. Subsequently, the regulatory effect of miRNA-485-5p on SALL4 level was evaluated. Rescue experiments were conducted to uncover the role of miRNA-485-5p/SALL4 regulatory loop in regulating cellular behaviors of AML.
RESULTS: Compared with healthy controls, serum level of miRNA-485-5p was lower in AML patients. MiRNA-485-5p was similarly downregulated in AML cell lines. Overexpression of miRNA-485-5p stimulated proliferation and alleviated apoptosis in AML. SALL4 level was downregulated by transfection of miRNA-485-5p mimics in AML5 and U937 cells. Overexpression of SALL4 could reverse the regulatory effect of miRNA-485-5p on proliferative and apoptotic abilities of AML.
CONCLUSIONS: MiRNA-485-5p is downregulated in AML. Overexpression of miRNA-485-5p alleviates the malignant progression of AML through downregulating SALL4.

Free PDF Download

To cite this article

W.-L- Wang, H.-R. Wang, W.-G. Ji, S.-L. Guo, H.-X. Li, X.-Y. Xu
MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 11
Pages: 4842-4849
DOI: 10.26355/eurrev_201906_18071